for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cryolife Inc

CRY.N

Latest Trade

24.92USD

Change

-0.19(-0.76%)

Volume

21,190

Today's Range

24.82

 - 

25.18

52 Week Range

21.24

 - 

32.59

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
25.11
Open
25.00
Volume
21,190
3M AVG Volume
4.66
Today's High
25.18
Today's Low
24.82
52 Week High
32.59
52 Week Low
21.24
Shares Out (MIL)
37.50
Market Cap (MIL)
941.72
Forward P/E
273.83
Dividend (Yield %)
--

Next Event

Q4 2019 CryoLife Inc Earnings Release

Latest Developments

More

CryoLife Reports Third Quarter 2019 Financial Results

CryoLife Posts Q2 EPS Of $0.11

Cryolife Q1 NON-GAAP Earnings Per Share $0.04

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cryolife Inc

CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Industry

Medical Equipment & Supplies

Contact Info

1655 Roberts Blvd NW

+1.770.4193355

http://www.cryolife.com

Executive Leadership

James Patrick Mackin

Chairman of the Board, President, Chief Executive Officer, Director

D. Ashley Lee

Chief Financial Officer, Chief Operating Officer, Executive Vice President

Jean F. Holloway

Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

John E. Davis

Senior Vice President - Global Sales and Marketing

Michael S. Simpson

Senior Vice President, Regulatory Affairs and Quality Assurance

Key Stats

1.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.2K

2018

0.3K

2019(E)

0.3K
EPS (USD)

2016

0.480

2017

0.400

2018

0.260

2019(E)

0.282
Price To Earnings (TTM)
711.73
Price To Sales (TTM)
3.43
Price To Book (MRQ)
3.39
Price To Cash Flow (TTM)
49.30
Total Debt To Equity (MRQ)
79.90
LT Debt To Equity (MRQ)
79.26
Return on Investment (TTM)
0.25
Return on Equity (TTM)
0.24

Latest News

Latest News

BRIEF-Cryolife Inc Q4 Loss Per Share $0.09

* SEES FULL YEAR 2018 TOTAL REVENUES $250.0 MILLION - $256.0 MILLION

BRIEF-Cryolife Says On Dec 1 Co Entered Into A Credit And Guaranty Agreement

* CRYOLIFE INC SAYS ON DECEMBER 1, 2017 CO ENTERED INTO A CREDIT AND GUARANTY AGREEMENT - SEC FILING

BRIEF-Cryolife reports third quarter 2017 results

* Q3 earnings per share view $0.09 -- Thomson Reuters I/B/E/S

BRIEF-CryoLife reports Q2 GAAP earnings per share $0.09

* Q2 earnings per share view $0.10 -- Thomson Reuters I/B/E/S

BRIEF-CryoLife reports Q1 non-GAAP earnings per share $0.09

* CryoLife Inc sees 2017 non-GAAP income per common share $0.40 - $0.43

BRIEF-CryoLife reports Q4 adj. earnings per share $0.12

* CryoLife reports fourth quarter and full year 2016 financial results

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up